Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Price:
18.46 CNY
Market Closed
Updated:
May 18, 2024
Balance Sheet
Balance Sheet Decomposition
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
| Current Assets | 162.4B |
| Cash & Short-Term Investments | 38.7B |
| Receivables | 81.9B |
| Other Current Assets | 41.8B |
| Non-Current Assets | 49.5B |
| Long-Term Investments | 10.9B |
| PP&E | 18.3B |
| Intangibles | 17.8B |
| Other Non-Current Assets | 2.6B |
| Current Liabilities | 122.4B |
| Accounts Payable | 47.9B |
| Accrued Liabilities | 10.9B |
| Short-Term Debt | 51.6B |
| Other Current Liabilities | 11.9B |
| Non-Current Liabilities | 21.1B |
| Long-Term Debt | 7.3B |
| Other Non-Current Liabilities | 13.7B |
Balance Sheet
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
Currency: CNY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
11 609
|
12 039
|
11 967
|
14 842
|
18 694
|
18 083
|
22 227
|
2 072
|
27 238
|
27 500
|
|
| Cash |
8
|
9
|
8
|
11
|
6
|
6
|
8
|
5
|
24 534
|
27 500
|
|
| Cash Equivalents |
11 601
|
12 030
|
11 959
|
14 831
|
18 688
|
18 077
|
22 219
|
2 067
|
2 705
|
0
|
|
| Short-Term Investments |
1
|
1
|
4
|
1
|
5
|
3
|
1
|
0
|
9 614
|
11 197
|
|
| Total Receivables |
22 519
|
26 383
|
30 162
|
34 454
|
46 642
|
52 234
|
57 719
|
63 759
|
73 225
|
81 948
|
|
| Accounts Receivables |
19 941
|
24 215
|
27 293
|
31 377
|
42 152
|
47 340
|
52 746
|
58 108
|
66 760
|
72 934
|
|
| Other Receivables |
2 578
|
2 168
|
2 869
|
3 077
|
4 490
|
4 894
|
4 973
|
5 651
|
6 465
|
9 014
|
|
| Inventory |
13 088
|
15 091
|
16 416
|
17 270
|
25 024
|
24 877
|
24 088
|
27 104
|
34 460
|
36 623
|
|
| Other Current Assets |
1 443
|
2 071
|
1 719
|
2 075
|
2 912
|
2 894
|
3 528
|
3 427
|
4 975
|
5 166
|
|
| Total Current Assets |
48 658
|
55 585
|
60 267
|
68 642
|
93 278
|
98 092
|
107 563
|
116 494
|
149 513
|
162 434
|
|
| PP&E Net |
4 994
|
6 091
|
6 966
|
9 100
|
10 604
|
13 128
|
14 626
|
16 128
|
16 542
|
18 279
|
|
| PP&E Gross |
4 994
|
6 091
|
6 966
|
9 100
|
10 604
|
13 128
|
14 626
|
16 128
|
16 542
|
18 279
|
|
| Accumulated Depreciation |
3 753
|
3 920
|
4 187
|
4 643
|
5 267
|
7 481
|
8 820
|
9 760
|
10 773
|
11 969
|
|
| Intangible Assets |
1 862
|
1 984
|
2 767
|
2 702
|
4 283
|
4 142
|
5 419
|
6 309
|
6 587
|
6 361
|
|
| Goodwill |
4 473
|
4 816
|
5 848
|
6 607
|
11 345
|
10 790
|
11 342
|
11 239
|
11 336
|
11 393
|
|
| Note Receivable |
253
|
333
|
425
|
581
|
316
|
266
|
170
|
198
|
212
|
228
|
|
| Long-Term Investments |
3 229
|
4 249
|
4 826
|
5 125
|
4 954
|
5 725
|
7 898
|
11 049
|
11 724
|
10 917
|
|
| Other Long-Term Assets |
872
|
1 286
|
1 644
|
1 586
|
2 098
|
4 885
|
2 167
|
2 018
|
2 221
|
2 360
|
|
| Other Assets |
4 473
|
4 816
|
5 848
|
6 607
|
11 345
|
10 790
|
11 342
|
11 239
|
11 336
|
11 393
|
|
| Total Assets |
64 341
N/A
|
74 344
+16%
|
82 743
+11%
|
94 344
+14%
|
126 879
+34%
|
137 026
+8%
|
149 186
+9%
|
163 436
+10%
|
198 135
+21%
|
211 973
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
17 150
|
20 674
|
22 307
|
23 346
|
30 975
|
31 819
|
32 861
|
37 231
|
45 604
|
47 915
|
|
| Accrued Liabilities |
710
|
773
|
1 017
|
1 222
|
1 187
|
1 561
|
1 348
|
1 656
|
2 588
|
10 950
|
|
| Short-Term Debt |
11 218
|
14 152
|
13 306
|
17 695
|
23 514
|
28 192
|
30 014
|
36 289
|
39 715
|
51 572
|
|
| Current Portion of Long-Term Debt |
21
|
290
|
5
|
6
|
2 007
|
1 186
|
8 885
|
578
|
3 229
|
2 963
|
|
| Other Current Liabilities |
2 903
|
3 537
|
4 478
|
7 363
|
11 028
|
11 850
|
15 024
|
16 070
|
19 555
|
8 972
|
|
| Total Current Liabilities |
32 003
|
39 427
|
41 113
|
49 632
|
68 710
|
74 608
|
88 133
|
91 824
|
110 691
|
122 372
|
|
| Long-Term Debt |
107
|
94
|
2 864
|
2 982
|
9 638
|
10 290
|
2 685
|
8 592
|
7 561
|
7 336
|
|
| Deferred Income Tax |
380
|
392
|
492
|
620
|
867
|
810
|
832
|
999
|
1 049
|
1 016
|
|
| Minority Interest |
3 277
|
3 878
|
5 212
|
5 645
|
7 420
|
7 727
|
9 386
|
9 707
|
10 939
|
11 802
|
|
| Other Liabilities |
752
|
623
|
1 439
|
1 434
|
1 231
|
1 933
|
2 794
|
2 954
|
831
|
923
|
|
| Total Liabilities |
36 518
N/A
|
44 414
+22%
|
51 120
+15%
|
60 314
+18%
|
87 866
+46%
|
95 367
+9%
|
103 831
+9%
|
114 076
+10%
|
131 072
+15%
|
143 448
+9%
|
|
| Equity | |||||||||||
| Common Stock |
2 689
|
2 689
|
2 689
|
2 689
|
2 842
|
2 842
|
2 842
|
2 842
|
3 698
|
3 703
|
|
| Retained Earnings |
10 968
|
13 060
|
15 354
|
17 900
|
20 819
|
23 639
|
26 880
|
30 591
|
34 639
|
36 129
|
|
| Additional Paid In Capital |
14 152
|
14 146
|
13 558
|
13 507
|
15 845
|
15 721
|
15 898
|
16 071
|
29 098
|
29 188
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
27
|
|
| Other Equity |
13
|
35
|
21
|
65
|
493
|
542
|
265
|
144
|
390
|
469
|
|
| Total Equity |
27 822
N/A
|
29 930
+8%
|
31 623
+6%
|
34 031
+8%
|
39 014
+15%
|
41 659
+7%
|
45 355
+9%
|
49 359
+9%
|
67 063
+36%
|
68 524
+2%
|
|
| Total Liabilities & Equity |
64 341
N/A
|
74 344
+16%
|
82 743
+11%
|
94 344
+14%
|
126 879
+34%
|
137 026
+8%
|
149 186
+9%
|
163 436
+10%
|
198 135
+21%
|
211 973
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2 689
|
2 689
|
2 689
|
2 689
|
2 842
|
2 842
|
2 842
|
2 842
|
3 698
|
3 703
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
